TransMedics Group, Inc. Increase (Decrease) in Inventories
TransMedics Group, Inc. (TMDX) reported Increase (Decrease) in Inventories of $10.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-04
- TransMedics Group, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $6.35M.
- TransMedics Group, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $3.90M.
- TransMedics Group, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $6.53M.
- TransMedics Group, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $6.90M, a 51.43% increase year-over-year.
- TransMedics Group, Inc. increase (decrease) in inventories for fiscal 2025 was $7.72M, a 7.63% decline from fiscal 2024.
- TransMedics Group, Inc. increase (decrease) in inventories for fiscal 2024 was $8.35M, a 70.27% decline from fiscal 2023.
- TransMedics Group, Inc. increase (decrease) in inventories for fiscal 2023 was $28.09M, a 250.10% increase from fiscal 2022.
- TransMedics Group, Inc. increase (decrease) in inventories for fiscal 2022 was $8.02M, a 63.96% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.25M 10-Q · filed 2026-08-04 | $16.78M derived: sum of 3 quarters · filed 2026-08-04 | $23.68M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.90M 10-Q · filed 2026-05-05 | $10.43M derived: sum of 2 quarters · filed 2026-05-05 | $17.33M derived: sum of 3 quarters · filed 2026-05-05 | $13.62M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $13.43M derived: sum of 2 quarters · filed 2026-02-24 | $9.72M derived: sum of 3 quarters · filed 2026-08-04 | $7.72M 10-K · filed 2026-02-24 |
| 2025-09-30 | $6.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.19M derived: sum of 2 quarters · filed 2026-08-04 | $1.19M 10-Q · filed 2025-10-29 | -$2.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$5.72M 10-Q · filed 2026-08-04 | -$9.85M derived: sum of 3 quarters · filed 2026-08-04 | -$5.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$2.00M 10-Q · filed 2026-05-05 | -$6.14M derived: sum of 2 quarters · filed 2026-05-05 | -$1.58M derived: sum of 3 quarters · filed 2026-05-05 | $737.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $421.00K derived: sum of 2 quarters · filed 2026-02-24 | $2.74M derived: sum of 3 quarters · filed 2026-02-24 | $8.35M 10-K · filed 2026-02-24 |
| 2024-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $6.88M derived: sum of 2 quarters · filed 2025-10-29 | $12.49M 10-Q · filed 2025-10-29 | $19.55M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $7.93M 10-Q · filed 2025-07-30 | $14.99M derived: sum of 3 quarters · filed 2026-02-24 | $25.05M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $5.61M 10-Q · filed 2025-05-08 | $12.68M derived: sum of 2 quarters · filed 2026-02-24 | $22.73M derived: sum of 3 quarters · filed 2026-02-24 | $30.08M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $17.11M derived: sum of 2 quarters · filed 2026-02-24 | $24.47M derived: sum of 3 quarters · filed 2026-02-24 | $28.09M 10-K · filed 2026-02-24 |
| 2023-09-30 | $10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $17.41M derived: sum of 2 quarters · filed 2024-10-29 | $21.03M 10-Q · filed 2024-10-29 | $22.96M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $7.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $10.98M 10-Q · filed 2024-08-01 | $12.91M derived: sum of 3 quarters · filed 2025-02-27 | $14.85M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.62M 10-Q · filed 2024-05-02 | $5.55M derived: sum of 2 quarters · filed 2025-02-27 | $7.49M derived: sum of 3 quarters · filed 2025-02-27 | $8.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.87M derived: sum of 2 quarters · filed 2025-02-27 | $5.10M derived: sum of 3 quarters · filed 2025-02-27 | $8.02M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.17M derived: sum of 2 quarters · filed 2023-11-08 | $6.09M 10-Q · filed 2023-11-08 | $7.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $4.15M 10-Q · filed 2023-08-04 | $5.08M derived: sum of 3 quarters · filed 2024-02-27 | $7.15M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $2.93M 10-Q · filed 2023-05-04 | $3.86M derived: sum of 2 quarters · filed 2024-02-27 | $5.93M derived: sum of 3 quarters · filed 2024-02-27 | $7.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.00M derived: sum of 2 quarters · filed 2024-02-27 | $4.51M derived: sum of 3 quarters · filed 2024-02-27 | $4.89M 10-K · filed 2024-02-27 |
| 2021-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $3.58M derived: sum of 2 quarters · filed 2022-11-04 | $3.96M 10-Q · filed 2022-11-04 | $3.31M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.89M 10-Q · filed 2022-08-03 | $1.24M derived: sum of 3 quarters · filed 2023-02-27 | $2.23M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $381.00K 10-Q · filed 2022-05-05 | -$276.00K derived: sum of 2 quarters · filed 2023-02-27 | $712.00K derived: sum of 3 quarters · filed 2023-02-27 | $1.88M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $331.00K derived: sum of 2 quarters · filed 2023-02-27 | $1.50M derived: sum of 3 quarters · filed 2023-02-27 | $1.74M 10-K · filed 2023-02-27 |
| 2020-09-30 | $988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.16M derived: sum of 2 quarters · filed 2021-11-09 | $2.40M 10-Q · filed 2021-11-09 | $3.28M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.41M 10-Q · filed 2021-08-06 | $2.29M derived: sum of 3 quarters · filed 2021-05-07 | $2.30M derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $241.00K 10-Q · filed 2021-05-07 | $1.12M derived: sum of 2 quarters · filed 2021-05-07 | $1.14M derived: sum of 3 quarters · filed 2021-05-07 | $1.89M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $883.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $895.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.65M derived: sum of 3 quarters · filed 2021-03-11 | $4.12M 10-K · filed 2021-03-11 |
| 2019-09-28 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $770.00K derived: sum of 2 quarters · filed 2020-08-07 | $3.24M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $758.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.23M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $2.47M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $2.70M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $2.82M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $850.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.03M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $1.18M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |